+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Copper chelation chemistry and its role in copper radiopharmaceuticals



Copper chelation chemistry and its role in copper radiopharmaceuticals



Current Pharmaceutical Design 13(1): 3-16



Molecular imaging is an important scientific discipline that plays a major role in clinical medicine and pharmaceutical development. While several imaging modalities including X-ray computed tomography (CT) and magnetic resonance imaging (MRI) generate high-resolution anatomical images, positron emission tomography (PET) and single photon emission computed tomography (SPECT) offer insight into the physiological processes that occur within a living organism. Of these two nuclear medicine imaging techniques, PET has advantages with respect to sensitivity and resolution, and this has led to the production and development of many positron emitting radionuclides that include non-traditional radionuclides of the transition metals. Copper-64 (t(1/2) = 12.7 h, beta(+): 17.4%, E(beta+max) = 656 keV; beta(-): 39%, E(beta-max) = 573 keV) has emerged as an important positron emitting radionuclide that has the potential for use in diagnostic imaging and radiotherapy. However, (64)Cu must be delivered to the living system as a stable complex that is attached to a biological targeting molecule for effective imaging and therapy. Therefore, significant research has been devoted to the development of ligands that can stably chelate (64)Cu. This review discusses the necessary characteristics of an effective (64)Cu chelator, while highlighting the development and evaluation of (64)Cu-complexes attached to biologically-targeted ligands.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 048663980

Download citation: RISBibTeXText

PMID: 17266585


Related references

Copper Chelation Chemistry and its Role in Copper Radiopharmaceuticals. Current Pharmaceutical Design 13(1): 3-16, 2007

The role of coordination chemistry in the development of copper and rhenium radiopharmaceuticals. Dalton Transactions 40(5): 999-1010, 2011

Iatrogenic copper deficiency associated with long-term copper chelation for treatment of copper storage disease in a Bedlington Terrier. Journal of the American Veterinary Medical Association 218(10): 1593, 2001

The chemistry of copper binding to PrP: is there sufficient evidence to elucidate a role for copper in protein function?. Biochemical Journal 410(2): 237-244, 2008

In vivo comparison of copper blood-pool agents: potential radiopharmaceuticals for use with copper-62. Journal of Nuclear Medicine 32(3): 475-480, 1991

Acetylacetonate bis(thiosemicarbazone) complexes of copper and nickel: towards new copper radiopharmaceuticals. Dalton Transactions 2004(16): 2404-2412, 2004

Chemistry of copper trimercaptotriazine (TMT) compounds and removal of copper from copper-ammine species by TMT. Applied Organometallic Chemistry 20(4): 246-253, 2006

Surface chemistry of copper metal and copper oxide atomic layer deposition from copper(ii) acetylacetonate: a combined first-principles and reactive molecular dynamics study. Physical Chemistry Chemical Physics 17(40): 26892-26902, 2015

Copper complexes of thiosemicarbazone-pyridylhydrazine (THYNIC) hybrid ligands: a new versatile potential bifunctional chelator for copper radiopharmaceuticals. Inorganic Chemistry 45(2): 496-498, 2006

A new zinc-62/copper-62 generator as a copper-62 source for PET radiopharmaceuticals. Journal of Nuclear Medicine 30(11): 1838-1842, 1989

Copper induces--and copper chelation by tetrathiomolybdate inhibits--endothelial activation in vitro. Redox Report 19(1): 40-48, 2014

Metal binding in chelation therapy x ray crystal structure of a copper i copper ii complex of d penicillamine. Journal of the Chemical Society Chemical Communications (9): 312-313, 1976

The disastrous copper. Comparing extraction and chelation treatments to face the threat of copper-containing inks on cellulose. Carbohydrate Polymers 206: 198-209, 2019

Diabetic cardiomyopathy is associated with defective myocellular copper regulation and both defects are rectified by divalent copper chelation. Cardiovascular Diabetology 13: 100, 2014

Blue copper proteins synthesis chemistry and spectroscopy of copper i and copper ii active site approximations crystal structure of potassium p nitrobenzenethiolatohydrotris 3 5 dimethyl 1 pyrazolylborato cuprate i di acetone. Journal of the American Chemical Society 101(15): 4180-4192, 1979